Pedro Pujante

731 total citations
35 papers, 182 citations indexed

About

Pedro Pujante is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Pedro Pujante has authored 35 papers receiving a total of 182 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Surgery and 8 papers in Molecular Biology. Recurrent topics in Pedro Pujante's work include Diabetes Treatment and Management (16 papers), Diabetes Management and Research (13 papers) and Pancreatic function and diabetes (8 papers). Pedro Pujante is often cited by papers focused on Diabetes Treatment and Management (16 papers), Diabetes Management and Research (13 papers) and Pancreatic function and diabetes (8 papers). Pedro Pujante collaborates with scholars based in Spain, United States and Mexico. Pedro Pujante's co-authors include Javier Salvador, Gema Frühbeck, Cristina Abreu, Edelmiro Menéndez Torre, Elías Delgado, S. Santos, Juan C. Galofré, Francisco Guillén‐Grima, Camilo Silva and Javier Tébar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes Care and Diabetes.

In The Last Decade

Pedro Pujante

28 papers receiving 179 citations

Peers

Pedro Pujante

EDM

PHYSI

SURGE

GENET

Caren Sourij Austria

Mathilde Svendstrup Denmark

Noémie Dubois France

Peter N. Pferschy Austria

Signe Frøssing Denmark

Jong Seo Yoon South Korea

Rafael Alexandre Meneguz‐Moreno Brazil

P. M. J. Zelissen Netherlands

Ornella Verrastro Italy

Jolanta Nawrocka-Rutkowska Poland

Caren Sourij Austria

Pedro Pujante

146 ×1.7

EDM

90 ×1.6

PHYSI

72 ×1.3

SURGE

57 ×1.6

GENET

33 ×1.6

Citations per year, relative to Pedro Pujante Pedro Pujante (= 1×) peers Caren Sourij

Countries citing papers authored by Pedro Pujante

Since Specialization

Citations

This map shows the geographic impact of Pedro Pujante's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro Pujante with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro Pujante more than expected).

Fields of papers citing papers by Pedro Pujante

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pedro Pujante. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro Pujante. The network helps show where Pedro Pujante may publish in the future.

Co-authorship network of co-authors of Pedro Pujante

This figure shows the co-authorship network connecting the top 25 collaborators of Pedro Pujante. A scholar is included among the top collaborators of Pedro Pujante based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pedro Pujante. Pedro Pujante is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jiménez‐Fonseca, Paula, et al.. (2025). The Influence of Performance Status, Inflammation, and Nutrition on the Impact of SGLT2 Inhibitors on Cancer Outcomes. Cancer Medicine. 14(6). e70807–e70807. 3 indexed citations

García, Ana Victoria, Javier Fernández, Pedro Pujante, et al.. (2025). The miR-200 family in the context of obesity and type 2 diabetes. Diabetes Research and Clinical Practice. 229. 112911–112911.

Martínez‐Camblor, Pablo, Ana Victoria García, Pedro Pujante, et al.. (2025). Impact of general practitioner appointment frequency on disease management in type 2 diabetes mellitus patients. Primary care diabetes. 19(2). 165–172.

Pujante, Pedro, et al.. (2024). Myxedema Coma as a Presentation of Panhypopituitarism Secondary to Traumatic Brain Injury. SHILAP Revista de lepidopterología. 2024(1). 3588840–3588840.

García, Ana Victoria, Jèssica Latorre, Pedro Pujante, et al.. (2024). Exploring differential miRNA expression profiles in muscular and visceral adipose tissue of patients with severe obesity. International Journal of Obesity. 49(4). 634–641. 1 indexed citations

García, Ana Victoria, et al.. (2024). Hypoglycemia during hyperosmolar hyperglycemic crises is associated with long-term mortality. Diabetology & Metabolic Syndrome. 16(1). 83–83. 3 indexed citations

García, Ana Victoria, et al.. (2024). Metformin and Glucose Concentration as Limiting Factors in Retinal Pigment Epithelial Cell Viability and Proliferation. International Journal of Molecular Sciences. 25(5). 2637–2637. 1 indexed citations

Pujante, Pedro, et al.. (2023). miR-24-3p and Body Mass Index as Type 2 Diabetes Risk Factors in Spanish Women 15 Years after Gestational Diabetes Mellitus Diagnosis. International Journal of Molecular Sciences. 24(2). 1152–1152. 7 indexed citations

Gómez‐Peralta, Fernando, Amanda López Picado, Cristina Abreu, et al.. (2023). Ultrarapid Insulin Use Can Reduce Postprandial Hyperglycemia and Late Hypoglycemia, Even in Delayed Insulin Injections: A Connected Insulin Cap-Based Real-World Study. Diabetes Technology & Therapeutics. 26(1). 1–10. 5 indexed citations

10.

García, Ana Victoria, Juan Ramón Tejedor, Mario F. Fraga, et al.. (2023). Circulating miRNA expression in long-standing type 1 diabetes mellitus. Scientific Reports. 13(1). 8611–8611. 16 indexed citations

11.

Pujante, Pedro, et al.. (2022). Correlation between glucose measurement parameters of continuous flash monitoring and HbA1c. Real life experience in Asturias. Endocrinología Diabetes y Nutrición (English ed ). 69(7). 493–499. 5 indexed citations

12.

Pujante, Pedro, et al.. (2021). Enfermedades cardiovasculares en personas con diabetes mellitus en España según la Base de Datos Clínicos de Atención Primaria (BDCAP) en 2017. Medicina Clínica. 158(4). 153–158. 3 indexed citations

13.

Pujante, Pedro, et al.. (2018). Efficacy of sodium glucose cotransporter 2 inhibitors as an adjunct treatment for patients with diabetes type 2. Medicina Clínica. 152(11). 438–441. 2 indexed citations

14.

Pujante, Pedro, et al.. (2018). Experiencia tras el cambio de insulina glargina U100 a glargina U300 en pacientes con diabetes tipo 1. Estudio tras un año de tratamiento en vida real. Endocrinología Diabetes y Nutrición. 66(4). 210–216. 1 indexed citations

15.

Pujante, Pedro, et al.. (2013). Modification of Cardiometabolic Profile in Obese Diabetic Patients After Bariatric Surgery: Changes in Cardiovascular Risk. Revista Española de Cardiología (English Edition). 66(10). 812–818. 6 indexed citations

16.

Pujante, Pedro, et al.. (2013). Evolution of Biochemical Effects of Byetta<sup>®</sup> in Type 2 Diabetics with Cardiovascular Risk. Pharmacology & Pharmacy. 4(9). 679–683.

17.

Pujante, Pedro, et al.. (2011). Control metabólico y pérdida de peso en pacientes con obesidad y diabetes mellitus tipo 2 tratados con exenatida. Medicina Clínica. 139(13). 572–578. 4 indexed citations

18.

Galofré, Juan C., Pedro Pujante, Cristina Abreu, et al.. (2008). Relationship between Thyroid-Stimulating Hormone and Insulin in Euthyroid Obese Men. Annals of Nutrition and Metabolism. 53(3-4). 188–194. 40 indexed citations

19.

Salvador, Javier, Camilo Silva, Pedro Pujante, & Gema Frühbeck. (2008). Obesidad abdominal: un estandarte del riesgo cardiometabólico. Endocrinología y Nutrición. 55(9). 420–432. 11 indexed citations

20.

Aerde, John Van, Pedro Pujante, Wayne Lam, et al.. (2003). Tolerance and Safety of Energy-Dense Enteral Formulae for Young Children. Acceda (Universidad de Las Palmas de Gran Canaria). 18(2). 95–99. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact